The latest closing stock price for Monte Rosa Therapeutics as of September 19, 2024 is 6.25.
An investor who bought $1,000 worth of Monte Rosa Therapeutics stock at the IPO in 2021 would have $-705 today, roughly -1 times their original investment - a -33.42% compound annual growth rate over 3 years.
The all-time high Monte Rosa Therapeutics stock closing price was 42.21 on September 03, 2021.
The Monte Rosa Therapeutics 52-week high stock price is 8.84, which is 41.4% above the current share price.
The Monte Rosa Therapeutics 52-week low stock price is 2.44, which is 61% below the current share price.
The average Monte Rosa Therapeutics stock price for the last 52 weeks is 4.99.
An investor who bought $1,000 worth of Monte Rosa Therapeutics stock at the IPO in 2021 would have $-705 today, roughly -1 times their original investment - a -33.42% compound annual growth rate over 3 years.
The all-time high Monte Rosa Therapeutics stock closing price was 42.21 on September 03, 2021.
The Monte Rosa Therapeutics 52-week high stock price is 8.84, which is 41.4% above the current share price.
The Monte Rosa Therapeutics 52-week low stock price is 2.44, which is 61% below the current share price.
The average Monte Rosa Therapeutics stock price for the last 52 weeks is 4.99.